Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The team at NCIMI would like to express their thanks and support for our colleagues working in the NHS against rising pressures of the Coronavirus outbreak.

An I Heart NHS badge on a Union Flag

We wanted to firstly share our thanks to our NHS partners

"These are life-changing and unprecedented times. At NCIMI, we're immensely proud of the collaborations we have built with NHS staff.

"Our thoughts are with our frontline NHS colleagues as they tackle high demand for healthcare services in the wake of the COVID-19 pandemic. There will be much for us all to learn in the coming months, and at the very core of our work is finding solutions to the most complex health problems.

"To all healthcare professionals, thank you. Keep fighting the fight, we have your backs."

Dr Fergus Gleeson, Chief Medical Officer.

Fergus Gleeson

In terms of NCIMI activity, an update from Claire Bloomfield, NCIMI CEO:

"Our aim is to progress activity where it is possible, limit calls on NHS colleagues who are on the frontlines of the crisis, and to use our infrastructure to help where we can.

"We will be liaising with partners to develop contingency plans around what we can progress whilst NHS work force is busy focusing on the crisis, and what will have to be delayed or redesigned.

"We have had several requests for the NCIMI team to work directly on COVID related projects, and we will hope to seek your support with this in the coming days.

"We aim to limit communications with partners, to not fill up inboxes. If we are in touch it will be linked to Covid related work or to seek updates from you on how current priorities are likely to impact NCIMI work over the coming months.

"If there is work you think we can be helping with please do get in touch, and likewise if you have resources you think might be helpful on tackling the crisis please let us know - we are all in this together.

If anyone does have any questions, please do get in touch with me."

Email Claire 

Claire Bloomfield

Avianna is NCIMI's Clinical Research Manager.

What is your job and what does it entail?

My role at NCIMI is to support the development, set-up and delivery of projects across the NCIMI data collection centre network.

What do you enjoy about working with NCIMI?


Having worked for the NHS for almost a decade, I've experienced some of the delays and burdens on our healthcare system first-hand. Since joining the team at NCIMI, it's given me the opportunity to work with like-minded individuals and teams who all share the same passion to be at the forefront of a new field in healthcare imaging that could alleviate some of these pressures.

I've particularly enjoyed getting involved in our collaborative projects with the Behavioural Architects, EthoX and Future Care Capital and I welcome more information addressing the public concerns around the appropriate and ethical use of patient data, and the clinical, social and economic value of data from an NHS perspective.

What are the greatest challenges of your role?


The space we occupy is increasingly far ahead of where the current regulations are, so trying to fit our work into the existing frameworks requires original thinking and careful planning. It's important that valuable opportunities to implement AI are not delayed whilst also ensuring new technologies are implemented properly and safely.

What do you think the future of AI in healthcare is?


The use of augmented 'artificial' intelligence has a huge part to play in the future of healthcare, and we're only at the beginning of seeing what some of these subsets can do. Enabling individuals and companies with innovative ideas to access the rich source of data we have in our hospitals will allow us to tap into those subtle and complex patterns across our patient populations. I'm particularly looking forward to seeing how AI can drive personalised medicine, moving away from a 'one-size fits all' approach and improving the patient experience.

What do you do in your spare time?


When not at work, my partner and I are registered foster carers for sibling groups and emergency placements in the local area. When the house is a little quieter, I enjoy spending time with my 2 year old daughter who is learning about horticulture by growing her own fruit and vegetables in the garden which we use in our baking and cooking. At the end of April I'll be taking a short hiatus from NCIMI to welcome a little boy into our family.

To mark International Women's Day on 8 March plus Endometriosis Awareness Month during March, we talk to Keri Hildick – Chief Revenue Officer at Perspectum.

Perspectum is leading on one of NCIMI's exemplar projects, working with Dr Ippokratis Sarris, University of Oxford and King's Fertility, to bring together AI and medical imaging to meet unmet need for patients living with endometriosis.

Endometriosis is a condition where cells that are normally found inside the womb are found growing outside, causing bleeding and inflammation.

The condition was recently highlighted by the BBC for its devastating effect on women who suffer from it – beyond painful and heavy periods to affecting women's education, career, relationships and mental health.

Keri talks to us about how Perspectum and fellow NCIMI partners are looking at new ways to detect endometriosis.

What is your role within Perspectum and What does it involve?

I founded and headed up the Business Development Team, which is responsible for identifying and driving revenue. It's one thing to build fantastic products, it's another to take them to market and into the clinical. I also co-lead our Pharma Solutions Business Unit, which is dedicated to providing imaging services for clinical trials.

One thing about Perspectum that I value is that we really focus on the patient. Yes, we have an eye on how to make money, but ultimately, it's about how it's going to benefit people and improve the patient journey.

How did you work up to this role?

I joined the company five years ago, as head of business development.

I started out my career working in industry at GlaxoSmithKline, where I was involved in early drug discovery programmes. I moved into Academia, where I obtained a PhD in Molecular Neuroscience at the University of Bristol. During my PhD, I spent time at the Royal Society, working in policy engagement, and then joined a market research firm as an analyst, after completing my studies.

That brought me into the Liver Disease space (where Perspectum does most of its business today) but I was looking for something with a practical application.

It was a friend who referred me to Perspectum and our CEO, Banjo (Rajarshi Banerjee). When I joined, Perspectum had just obtained FDA clearance for its first product, LiverMultiScan. I was brought on as part of the company's commercial expansion.

Yes the role is around generating sales, but it's also about the strategy behind sales, identify suitable markets and being involved in the longer-term strategy for growth. Perspectum is certainly on a growth curve.

Our products are available in around 300 scanners worldwide, with a lot of our clinical trial work taking place in the US. LiverMultiScan was our first product but through our partnership with NCIMI, we are looking at disease indications in other organs.

What's great about working with NCIMI?

It's such a unique collection of expertise – we have University of Oxford, GE Healthcare, plus smaller, agile industry start-ups. It's a pretty exciting and unique collection of people Claire (Bloomfield – NCIMI' CEO) has pulled together.

It's really about bridging what we call the "Valley of Death" – the barrier to clinical adoption. Some of the technologies we develop in industry never manage to make it into the clinical space.

But through NCIMI we are taking the concept of advanced medical imaging and AI and creating pathways to apply them to improve standard of care. We are able to see across the life cycle of different products, from concept to development right to use in a clinical context.

There is huge potential in AI in healthcare, and through NCIMI we can unlock it.

What work is Perspectum inputting to the NCIMI network?

We are working at the cutting edge of diagnosis of endometriosis. We're keen to raise awareness of this condition - It can be as common as diabetes amongst women. And it's not one condition – it presents in different ways.

Currently, endometriosis can take, on average, seven and half years to diagnose. Usually this is via laparoscopy – an invasive procedure.

We are looking at the current pathway to understand if we can improve the precision with which certain types of endometriosis are diagnosed, using a combination of ultrasound and advanced MRI. In particular, this could help with deep-infiltrating endometriosis – an advanced stage of the disease where the invading endometrial tissue is 5mm deep or more.

As part of the project we will be exploring image fusion of ultrasound and MRI.

This a new venture for Perspectum. It's also the only women's health exemplar within NCIMI, so that's unique and exciting.

We're also building our partnership with the patient associations, such as Endometriosis UK. We've engaged with them to enable Perspectum to become an Endometriosis friendly employer for any of our staff who may need support. We know this affects 10% of women, and is the cause of 30% of fertility problems - with around 200 employees, over half of whom are female, there are going to be colleagues who are affected.

Perspectum is also involved with two other exemplar projects with NCIMI – Assessing diabetes with multi-organ imaging, and early identification of haemochromatosis, using our LiverMultiScan imaging software.

How will you be celebrating International Women's Day?

It's a Sunday this year, so I will be spending it with my 7-month-old son. I'll probably be taking him swimming and enjoying some downtime.

I'm returning to work in two weeks' time, and my husband is taking over with paternity leave.

When you work for a company you are passionate about, and where colleagues are also friends, it's easy to keep in touch with the team. My son has been in his first business meeting already and I've had a few calls with him in the background. I think his first word will be "endometriosis"!

Perspectum is a family-friendly company to work for. Our CEO has two small children too, and we have a family room set up in our offices, where you can bring your kids in for the day if needed.

I hope to be setting a good example to him - they say children of working mums go on to be really successful!

Keri Hildick and her son

Ground-breaking medical technology which could help save the lives of hundreds of stroke patients is being pioneered at Reading's Royal Berkshire Hospital.

From left to right: Dr Varun Nelatur, Consultant Stroke Physician, RBH; Dr Kiruba Nagaratnam, Consultant Stroke Physician and Geriatrician and Clinical Lead for Stroke Medicine at the RBH; Dr George Harston, Chief Medical Officer at Brainomix; Claire Bloomfield, CEO of NCIMI.
From left to right: Dr Varun Nelatur, Consultant Stroke Physician, Royal Berkshire Hospital; Dr Kiruba Nagaratnam, Consultant Stroke Physician and Geriatrician and Clinical Lead for Stroke Medicine at the RBH; Dr George Harston, Chief Medical Officer, Brainomix and Claire Bloomfield, CEO of NCIMI.

It's the first hospital in the Thames Valley to start using the cutting-edge AI software. It is already used in hundreds of hospitals across Europe, Asia, North and South America.

The software, developed by Oxford-based Brainomix, was launched on Tuesday, February 25 - at Royal Berkshire Hospital. It will go live in March 2020 and will be used in the Emergency Department (ED) to help clinicians quickly diagnose stroke.

This in turn will speed up doctors' decision making around treatment and, when necessary, fast forward certain patients to specialist centres for clot retrieval treatment.

The AI software analyses the CT images of the brain and its blood vessels immediately after the patient has a scan, automatically highlighting the area of probable damage and the blocked blood vessel. This means it acts as an expert second opinion and helps the physicians make faster treatment decisions with confidence.

Dr Kiruba Nagaratnam, Consultant Stroke Physician and Geriatrician, and Clinical Lead for Stroke Medicine at the RBH, said the software would transform patient care for stroke victims.

He said: "Interpreting CT brain scans is an essential part of the diagnosis and management of strokes. But this expertise is not always readily available the minute people come through the doors of ED. Interpreting scans of the blood vessels adds another layer of complexity and causes delays.

"Time is essential and 2 million nerve cells die every minute we delay the treatment. The role of AI in helping non specialist doctors to rapidly identify and treat strokes at the front door when people walk into ED, is going to be a game changer."

Dr Michalis Papadakis, CEO of Brainomix, said: "We are very pleased to see Royal Berkshire incorporate our e-Stroke Suite software into their stroke service, and are confident our technology can deliver solutions that will help improve access to life-saving treatments for stroke patients in the region."

The deployment of the Brainomix e-stroke suite is being supported by NCIMI, which is for 5 Centres of Excellence in the UK supporting companies, the NHS and Universities work together with patients to collaborate on AI development in medical imaging.

Dr Claire Bloomfield, NCIMI's CEO, said: "We are delighted to support innovative companies and hospitals like Royal Berkshire and Brainomix in the development and deployment of AI software to improve patient care. We hope to help the further expansion of this fantastic technology across the rest of the NCIMI network."

The Oxford Academic Health Science Network, which is supporting this pioneering venture, also welcomed the launch of the software at the RBH.

Brainomix is a world leader in imaging software for neurological and cerebrovascular diseases, whose award-winning e-Stroke Suite provides clinicians with the most comprehensive stroke imaging solution.

National Consortium of Intelligent Medical Imaging (NCIMI) is a network of 14 NHS hospitals, clinical leaders, industry experts in the fields of AI and medical imaging, world-leading academic researchers plus patient groups and charities. It was formed in 2019 following a successful bid for Industrial Strategy Challenge Funding (ISCF) to drive innovation in the UK's AI sector, and is one of 5 National Centres of Excellence in AI for pathology and medical imaging.

Brainomix has received funding from Innovate UK, part of UK Research and Innovation (UKRI) and also from NCIMI, which itself also receives funding from UKRI through ISCF.

Amied Shadmaan is Senior Program Manager - Artificial Intelligence Clinical Partnerships at GE Healthcare, and works closely with the NCIMI team. As the largest commercial partner in the NCIMI consortium, GE Healthcare is well placed to take ideas from brain to bedside by sharing talent, software, and equipment.

Photograph of a doctor showing a lung image on a digital device or tablet.

 

GE Healthcare's Centricity Clinical Archive is a key element of the partnership. It is the foundational technology for data collection and storage and management of protected data from the participating NHS trusts and will be under governance of the Big Data Institute at the University of Oxford.

We ask Amied why GE and NCIMI make the ideal partnership.

Why is it important for GE Healthcare to be part of NCIMI?

It's an exciting time. MedTech and Al promise to change the landscape for patients, healthcare professionals, hospitals and the NHS.

It has the potential to support earlier detection and prevention of some of the most common and challenging diseases, improving outcomes.

It could offer quicker, more accurate diagnoses and guide subsequent treatment decisions, so they're optimised for each individual. And it could improve efficiencies and operational workflows within hospitals, breaking down walls by creating one truly integrated system.

What makes NCIMI different to other networks or partnerships?

By bringing together a wide range of expertise into one sustainable ecosystem, NCIMI aims to address unmet needs in Al. The consortium provides the infrastructure needed to give industry access to patient data sets that inform multi-modality clinical imaging projects and software development, so that emerging projects can be disseminated and up-scaled across participating NHS trusts.

This is the first time such a multi-stakeholder approach has been adopted for clinical imaging and Al. Integrating different viewpoints to generate patient trust and added value from development to implementation and NHS adoption will give the consortium the power and insight to make Al in healthcare a reality.

What technologies are GE leading on in the AI and healthcare space?

We currently have three projects in development with NCIMI that use GE Healthcare's technologies:

1. PET/CT reconstruction

Why: PET scans are used to stage oncology patients and assess cancers. However, demand is high and the rapid and accurate quantification of lesions can be difficult
How: Develop an algorithm that optimises signal recovery, thus providing superior image quality, as well as predicting how long you need to scan a patient for, and what the image will be like

2. Critical Care Suite
Why: Chest x-rays are the highest volume exam and commonly acquired frequently on the sickest patients. A critical finding requires immediate attention from the physician to stabilize the patient - and long radiologist turnaround times, delaying diagnosis, may put the patient in further danger.
How: Develop an algorithm that accurately locates and identifies critical findings, such as a pneumothorax or collapsed lung, and embed it within the x-ray device to flag cases within seconds of acquisition as needing immediate radiologist review.

3. PET/CT Al-assisted reader
Why: Radiologists in Oncology want to be able to read PET/CT images more quickly and confidently
How: Develop an algorithm detects and classifies cancer on patients' PET/CT images

What challenges are your organisation facing in the area of AI and healthcare?

There are a couple of key challenges we see: the world's perception of AI and data governance.

Perception of Al: A lack of understanding of Al can lead to the perception that it is a dangerous tool, taking decisions out of the hands of clinicians and leaving scope for error through automation. However, Al isn't intended to replace people, it's designed to support them.

Al offers a great opportunity to re-humanise healthcare by freeing up time for clinicians to interact at a human level with their patients. The role of listening and being there for a patient cannot be replaced by Al. Rather, it can help us diagnose faster and with more accuracy.

Data governance: One of the key factors that could undermine people's confidence in healthcare Al is poor data governance. Questions such as 'who owns my data?', 'what do they know?', 'who has access to it?', 'is it accurate?' and 'could it be misused?' are currently at the forefront of the public and professional conscience.

People are already sceptical about sharing their information with multinational, 'big data' companies. Recent scandals where data has been misused and shared without following the proper procedures and permissions have complicated matters further, undermining trust and confidence.

That's why GE and NCIMI are working continuously to ensure robust data governance flows through every aspect of our work, so our data remains both consistent and trustworthy.

What are you looking forward to developing within the NCIMI network?

Very little is certain in such a rapidly-evolving world. New opportunities present themselves; novel technologies are developed; and unique challenges arise.

It's clear that the old-fashioned methods of working are no longer fit for purpose. Al innovation will no longer be developed behind closed doors, but instead, it will thrive as part of a wider ecosystem, utilising the skills and expertise of many stakeholders to ensure an idea can become a reality. So, no matter where the future takes us, we'll have the academic, clinical and commercial insight needed to lead the way in healthcare transformation.

Read more about NCIMI and GE Healthcare's partnership through the whitepaper, Integrating Artificial Intelligence into Healthcare.

Find out the latest events we are attending and hosting this quarter.

Consortium Management Group

Our next meeting takes place on 11th February. Notes will be circulated in the coming weeks. 

To keep informed of latest developments, email: ncimi@oncology.ox.ac.uk 

Ethics in AI - 10 February

The next seminar in the Ethics in AI series will take place at 4pm on Monday of week 4 (10 February) in the Weston Library Lecture Theatre. The seminar will finish at around 5:45 pm, and will be followed by a drinks reception in Blackwell Hall, giving an opportunity for further discussion with the speakers.

This seminar will consist of the following three sessions:

1. AI in Healthcare (Mike Parker, Wellcome Centre; Claire Bloomfield, National Consortium of Intelligent Medical Imaging; Angeliki Kerasidou, Ethox Centre)
2. AI in Business and Finance (Nir Vulkan and Alan Morrison, Saïd Business School)
3. Values and AI: Views from Public Policy (Jo Wolff and Vafa Ghazavi, Blavatnik School of Government)

All staff and students are welcome, whatever their field. The event is free but please book via the following Eventbrite link to secure a place.

The third seminar of term will take place at 4pm on Monday of week 8 (9 March) in the Martin School. If you would like to be added to the seminar mailing list, please contact Jo at admin@philosophy.ox.ac.uk.

OxFest - 15 February 2020

NCIMI's CEO Claire Bloomfield will be joining a panel to discuss: Innovation and Entrepreneurship at the 9th Annual OxFEST conference.

OxFEST (Oxford Females in Engineering, Science, and Technology) is one of the largest student-led societies at the University of Oxford. It promotes gender equality in STEM subjects by supporting women studying or working in these fields, spreading awareness of diversity issues in STEM, and encouraging community members to become advocates.

A handful of tickets are still available at: https://oxfest.splashthat.com

Debating Data - 15 February 2020

Would you like to contribute to a fun and interesting one day event on 15th February 2020, debating how medical data is used in healthcare and research?

We will be working with our Oxford University colleagues to present cases for and against the use of healthcare data to a public audience inside the Oxford Town Hall Council Chamber. If this sounds of interest, please click here for further information and to sign up.


ECR Vienna - 11 - 15 March 

The NCIMI team are getting ready to attend the European Society of Radiology conference in Vienna next month. We'd love to hear from our partners who may be attending.

Email us to let us know what you will be attending, or which stand you'll be at.

ncimi@oncology.ox.ac.uk

NCIMI has appointed national charity Future Care Capital (FCC) on a project which could enable the NHS to better harness the value of health data and make use of medical imaging data to deliver patient and societal benefit.

The Big Data Institute at University of Oxford, where NCIMI is based.

NCIMI has appointed national charity Future Care Capital (FCC) on a project which could enable the NHS to better harness the value of health data and make use of medical imaging data to deliver patient and societal benefit.

The announcement comes amid growing awareness of the potential for clinical, social, economic development and commercial value to be derived from data controlled by and/or generated with the NHS.

Within a fast-evolving landscape for healthcare professionals, universities, companies and policymakers, the Government has published the second iteration of its Code of Conduct for Data-driven Health and Care Technology.

This includes an addendum which provides guiding commercial principles designed to 'Create the right framework to realise the benefits of health data'.

The Code of Conduct has also recognised the need to establish a National Centre of Expertise within NHSX to provide NHS organisations with the legal and commercial support they need to forge data agreements which maximise the value of such data and, in time, the Centre is expected to develop and improve articulation of a national policy framework in this important regard.

Advice and guidance to NHS trusts and entities who wish to enter into agreements with third parties is limited. NCIMI has, therefore, appointed Future Care Capital to explore how it might approach the development of an appropriate 'data value capture framework'.

Dr Claire Bloomfield of NCIMI said: "We are delighted to be working with FCC on what we consider a fundamental for NCIMI in developing medical imaging AI with our stakeholders – so that it produces benefit and value for all parties and we ensure we capture and define this in an collaborative and transparent manner."

Greg Allen, FCC's Chief Executive said: "We welcome this opportunity to work with NCIMI and its partners and we hope that the framework we develop will contribute to ensuring that health data is better valued and stewarded for the benefit of society and, ultimately, those who receive care."

The programme of work is designed to explore whether there is scope for the range of parties involved in NCIMI to distil and agree strategic priorities such that a differential value framework can be developed to guide agreements between individual data subjects, publicly funded and accountable health and care bodies, HEIs and commercial entities where broad-ranging data sets are involved. It will then test any resultant framework to derive lessons for dissemination and discussion with other interested parties.

Future Care Capital (FCC) is a charity which undertakes research to advance ideas that will help shape future health and social care policy and, with that, deliver better outcomes for individuals living in the UK.

Its work to enable key stakeholders to harness the value of healthcare data has involved extensive research, policy development and advocacy activity – impacting developments being led by HMT/Cabinet Office, DHSC and the Office for Life Sciences.

NCIMI and several of our partners including GEHC, Mirada Medical and Perspectum Diagnostics headed to Chicago in December for RSNA – the Radiological Society of North America annual conference.

It was a great chance to reconnect within international colleagues and hear more about the latest developments, in what was a surprisingly mild Chicago December.

There, we presented a GE Healthcare white paper – Integrating Artificial Intelligence into Healthcare. This highlighted two of our exemplar projects: Use of AI to improve oncology PET/CT clinical workflow and productivity, and use of algorithms in the critical care suite to identify critical findings on chest X-rays.

Claire said: "We were delighted to talk about the power of collaboration and partnership, and how we are keeping patients at the heart of everything we do.

"This white paper with GE highlights our commitment to working together. It was a chance to share the early impact of our work on a global stage, whilst also growing our network of contacts."

Claire also spoke at GE Digital's Connect event alongside ACR Chair Geraldine McGinty to discuss the future of AI in Radiology, and our model of collaboration in NCIMI and the potential to support untapped areas of need such as endometriosis.

Claire Bloomfield and GE Healthcare Digital Connect panel

NCIMI's Claire Bloomfield joins the GE Healthcare Digital Connect panel at RSNA.

The week also saw Claire, Fergus and Mike Brady attend the official launch event for the report from MIT Technology Review: The AI effect – How artificial intelligence is making health care more human. You can read more about the report, which includes discussion with Mike and findings of research amongst 900 healthcare professionals about their experience with AI, here.

Claire also joined an internal panel discussion for GE, hosted by with GE's Chief Medical Officer, Mathias Goyen to discuss the future of radiology with the incoming chair of the European Society of Radiology.

It was also a chance to tour the AI Showcase stands including those of our SME partners and GE’s technology stands, as well as making new connections for potential collaboration and to see the latest advances we can integrate into NCIMI.  

Following this, we are hosting GE international Digital Leadership team this coming month on 28th January, to discuss what new technology we can bring to NCIMI to support our partners in new algorithm development and deployment.

 

NCIMI team tour booths at RSNA.jpg

ABOVE: Fergus and Claire get an update from the GE team on the latest developments in TrueFidelity image reconstruction for CT, from GE Healthcare at their large main exhibition hall.

Mirada Medical at RSNA

ABOVE: The central Mirada Medical Stand in the AI Showcase.

BELOW: Perspectum Diagnostic's popular stand in the AI Showcase at RSNA.

Perspectum Diagnostics stand at RSNA

In the first of a series of Meet the Team profiles, here is a chance to get to know Kevin McGlynn - our Technical Programme Manager.

What is your job and what does it entail?

I am Technical Programme Manager.

I oversee the implementation of our image and meta data sharing network and central data bank and catalogue of clinical data. This involves various work streams of infrastructure setup and data flow initiation with our network of Trust Partner sites and meeting the needs of our industry exemplar project partners.

What do you enjoy most about working with NCIMI?

I love the dynamic team working and passion from and with our partners to positively affect the outcomes for the patients our AI projects will reach. Every day is different and every day has reminders of how we're helping our partners and NHS patients.

What are the greatest challenges of your role?

The greatest challenge is trying to implement a network that is new to our partners and needs to support activity across 15 NHS Trusts, all while trying to keep our governance requirements aligned with the needs of our partners.

What do you think the future of AI in healthcare is?

The future of AI in healthcare seems like it will become less of a buzzword, and more of a regular fact of life. We're likely to all benefit from most fields of healthcare adopting AI technology in the future. These technologies will empower GPs, radiographers, etc., to use more of their time on patient facing tasks and less of their time on admin/operations/etc.

What do you like to do outside your role with NCIMI?

In my spare time I'm active around Oxford with my two boys. I'm also an ice hockey player and coach with Oxford University's men's and women's ice hockey teams. I'm also a volunteer for the Green Party and have sat in local council elections over the last 6 years.


Kevin McGlynn playing ice hockey

Kevin on the ice with Oxford University's ice hockey team.

NCIMI CEO Claire Bloomfield is interviewed by GE Healthcare's Kieran Murphy.

© MIT

5 Questions with: Claire Bloomfield, CEO of the UK's National Consortium of Intelligent Medical Imaging (NCIMI) on The AI Effect, new research in MIT Technology Review

Read more on Kieran Murphy's LinkedIn article